WHO Abortion Care · EML Medical Abortion → Korea 인공임신중지 약물 → 성평등가족부
성평등가족부 (Ministry of Gender Equality and Family), 보건복지부 (Ministry of Health and Welfare), 식품의약품안전처 (Ministry of Food and Drug Safety)
Echo patterns are similarity-based hypotheses, not proof of causation. Open the sources and evaluate the linkage yourself.
Evidence Scorecard
Three lenses — wording, timing, documented link. Not a single proof score.
Could also be…show
- •Parallel domestic policy development is possible.
- •Industry or market pressure may have driven similar language.
- •A common external shock (e.g., financial crisis, pandemic) could explain parallel adoption.
Timeline of the echo
4 year lagFirst Korean mention2017 domestic feminist lexicon; 2026.09.16 drug brief
From date field: 2017– KR feminist 임신중지 lexicon → 2019 WHO EML / 2022 Abortion Care → 2024 NHRCK → 2026.9.16 인공임신중지 약물 도입 방안 · 2017–2027
Interrogate the Evidence
Answers are rendered directly from this record’s own curated fields — nothing is generated.
Csuggestive similarity · 84%
- SemanticStrong semantic alignment
- TemporalGlobal precedent precedes Korea
- LinkageNo recorded linkage
Matched concepts: medical abortion (mifepristone + misoprostol) ↔ 인공 임신중지 약물 도입; WHO Essential Medicines (core list) ↔ 필수의약품·식약처 허가 심사; domestic feminist lexicon (~2017–) ↔ 낙태·중절 → 임신중지 정책어휘
Cross-lingual similarity 11/100 (heuristic fallback) — a computed signal, not proof.
Similarity type: WHO medical abortion / EML → 인공임신중지 약물 | 낙태·중절 → 임신중지 lexicon = domestic feminist/rights (~2017–), not JP/CN/WHO English name loan
Caveat: semantic similarity only — this tier records a hypothesis, not proof of causal influence.
Matched Concepts
3 pairsAgenda Arc
CuratedGlobal purpose, Korean purpose, and precursor stages. Reasoning echo is discourse observation — not proof of coordination.
Move induced abortion from criminal stigma into evidence-based health-system care, including access to WHO-listed medical abortion medicines.
성평등가족부·보건복지부·식약처는 2026.9.16 국가정책조정회의에서 「인공 임신중지 약물 도입 방안」을 보고: 임신 9주(63일) 이하 약물 허가·심사, 도입 초기 2년 의료기관 내 의사 처방·조제, 2027년 1분기 도입 목표. 약물 경로(WHO EML·Abortion Care)와 별도로, 공식 보도어휘 「(인공)임신중지」는 일본 中絶·중국 人工流产 차용이 아니라 2017년 전후 국내 낙태죄 폐지·재생산권 운동이 「낙태」·「인공임신중절」을 밀어내고 정착시킨 페미니즘·권리 레시콘이다(서울시 성평등 언어사전 등 「임신중단」, 인권위 2024.9.25 「임신중지」 권고).
정책브리핑 · 임신중지 약물 정식 도입 추진 (성평등가족부, 2026.9.16) — 성평등가족부·보건복지부·식약처는 2026.9.16 국가정책조정회의에서 「인공 임신중지 약물 도입 방안」을 보고: 임신 9주(63일) 이하 약물 허가·심사, 도입 초기 2년 의료기관 내 의사 처방·조제, 2027년 1분기 도입 목표. 약물 경로(WHO EML·Abortion Care)와 별도로, 공식 보도어휘 「(인공)임신중지」는 일본 中絶·중국 人工流产 차용이 아니라 2017년 전후 국내 낙태죄 폐지·재생산권 운동이 「낙태」·「인공임신중절」을 밀어내고 정착시킨 페미니즘·권리 레시콘이다(서울시 성평등 언어사전 등 「임신중단」, 인권위 2024.9.25 「임신중지」 권고).
The word 임신중지 in 「인공 임신중지 약물」 is primarily a domestic feminist/rights lexicon (~2017– abortion-crime repeal and reproductive-justice organizing), not a Japan or China name loan and not a calque of WHO English "abortion". Japan still says 中絶 (cognate of Korea's older statute 인공임신중절); China says 人工流产 / 终止妊娠. Official briefs absorbed the activist term while the medicine pathway separately tracks WHO EML/Abortion Care.
WHO / HRP reproductive-health guidance + Essential Medicines List (drugs); Korean feminist/rights discourse ~2017– (lexicon)
Drug path: WHO EML + Abortion Care normalized medical abortion. Naming path: domestic activists replaced 낙태/중절 with 임신중지/임신중단; ministries later adopted that lexicon in the 2026 drug brief.
- StageKorea2017–Korean civil society / Seoul gender-equality language campaignsKorean feminist/rights lexicon: 낙태 → 임신중지
Abortion-crime repeal and reproductive-rights organizing popularize 임신중지/임신중단 over stigmatizing 낙태; later municipal language campaigns and NHRCK reinforce the swap.
- Soft lawGlobal2019–2022WHOWHO EML core listing + Abortion Care Guideline
Mifepristone–misoprostol move to EML core; 2022 guideline consolidates medical-abortion regimens as health care.
Primary source - RecommendationBridge2024NHRCKNHRCK: replace 낙태/중절 with 임신중지 + introduce EML drugs
National Human Rights Commission of Korea urges policy-term reform and introduction of pregnancy-termination medicines as essential medicines.
Primary source - StageKorea2026MOGEF / MOHW / MFDSJoint MOGEF/MOHW/MFDS 인공임신중지 약물 도입 방안
National Policy Coordination Council report uses the domestic 임신중지 lexicon and schedules MFDS-reviewed medical abortion drug introduction (≤9 weeks; clinic prescribe/dispense for first 2 years).
Primary source
WHO's Abortion Care Guideline (2022; updating prior Safe abortion guidance) treats induced abortion as essential② healthcare and recommends medical-abortion regimens (mifepristone① + misoprostol, or misoprostol alone). The WHO Model List of Essential Medicines lists mifepristone–misoprostol on the core list for induced abortion. English WHO vocabulary is "abortion care" / "medical abortion" — clinical and health-systems language, not criminal stigma.
성평등가족부·보건복지부·식약처는 2026.9.16 국가정책조정회의에서 「인공 임신중지 약물 도입① 방안」을 보고: 임신 9주(63일) 이하 약물 허가·심사, 도입 초기 2년 의료기관 내 의사 처방·조제, 2027년 1분기 도입 목표. 약물 경로(WHO EML·Abortion Care)와 별도로, 공식 보도어휘 「(인공)임신중지」는 일본 中絶·중국 人工流产 차용이 아니라 2017년 전후 국내 낙태죄 폐지·재생산권 운동이 「낙태」·「인공임신중절」을 밀어내고 정착시킨 페미니즘·권리 레시콘이다(서울시 성평등 언어사전 등 「임신중단」, 인권위 2024.9.25 「임신중지」 권고). 2019년 헌법불합치 이후 대체입법 공백 속에서 그 어휘가 정부 브리핑에 올라탄 경로.
Echo Strength
Influence Mechanism
Split claim: (1) drugs = WHO EML/Abortion Care → MFDS pathway; (2) 임신중지 naming = domestic feminist/rights lexicon from ~2017 abortion-crime repeal movement, later NHRCK/Seoul language campaigns — not JP 中絶, CN 人工流产, or WHO English lemma. JP explains legacy statute 인공임신중절 only.
2017–2027
WHO medical abortion / EML → 인공임신중지 약물 | 낙태·중절 → 임신중지 lexicon = domestic feminist/rights (~2017–), not JP/CN/WHO English name loan
Sources
Related Patterns
WHO Mental Health & Suicide Prevention Framework
WHO Pandemic Agreement (WHA78) → Korea Infectious Disease Law
CEDAW General Recommendation 35 (Gender-based violence) → Korea Framework Act on Prevention of Violence Against Women
CEDAW Article 7 (Political participation) → Korea Gender Equality Act & Political Parties Act
WHO Guidelines for Drinking-Water Quality → 환경부 먹는물 수질기준 고시 (ME Drinking Water Quality Notice)
SAICM / Global Framework on Chemicals → Korea Consumer Chemical Products Safety Act
Minamata Convention (Mercury-Added Products) → Korea Environmental Health Act
ILO/WHO Asbestos Convention → Korea Asbestos Safety Management Act